Yak Spleen Extract (Bos grunniens)
Yak spleen extract (Bos grunniens) is a glandular supplement containing bioactive peptides, transfer factors, and spleen-derived polypeptides that modulate immune signaling. Its primary mechanism involves regulating apoptosis through Bcl-2/Bax ratio modulation and supporting lymphocyte activity in preclinical models.

Origin & History
Yak spleen extract is derived from the spleen tissue of yaks (Bos grunniens), domesticated bovines native to the Qinghai-Tibetan Plateau. The extract is prepared using modern biotechnology methods including tissue extraction, separation, and purification, which allow the isolated proteins to be absorbed directly without requiring intestinal digestion.
Historical & Cultural Context
While specific historical use of yak spleen extract is not documented in available sources, yak-derived products are noted as having 'many sources' in the Qinghai-Tibetan Plateau region, suggesting regional traditional use. Detailed historical context for spleen-specific preparations is not provided in current literature.
Health Benefits
• May support immune organ function based on animal studies showing increased spleen and thymus indices • Potentially protects against radiation-induced cellular damage in preclinical models • May help regulate apoptosis by modulating Bcl-2 and Bax expression (animal evidence only) • Could support blood cell formation as suggested by improved hemogram results in irradiated mice • May possess anti-inflammatory properties through NF-κB pathway inhibition (based on related yak peptide research)
How It Works
Yak spleen extract contains spleen-derived polypeptides and transfer factors that appear to modulate the intrinsic apoptosis pathway by upregulating anti-apoptotic Bcl-2 expression while suppressing pro-apoptotic Bax expression, thereby altering the Bcl-2/Bax ratio in immune and hematopoietic cells. Bioactive peptides within the extract may also stimulate lymphocyte proliferation and enhance NK cell activity by interacting with immune cell surface receptors involved in innate immunity. Additionally, antioxidant constituents in the extract may scavenge reactive oxygen species (ROS) generated by ionizing radiation, partially explaining observed cytoprotective effects in irradiated animal models.
Scientific Research
Clinical evidence is limited to animal studies, with no human trials identified. A 2017 study investigated yak-activated protein in radiation-injured mice, finding improvements in immune organ indices and blood parameters. The extract modulated apoptosis markers and demonstrated protective effects at medium doses 14 days post-irradiation.
Clinical Summary
The evidence base for yak spleen extract consists almost entirely of preclinical animal studies, with no large-scale randomized controlled trials in humans published as of 2024. Rodent studies have demonstrated statistically significant increases in spleen and thymus organ indices following supplementation, suggesting immunotrophic activity, though translation to human physiology remains unconfirmed. Radiation protection studies in mice have shown reductions in bone marrow cell apoptosis and improved hematopoietic recovery post-irradiation at doses ranging from 100–400 mg/kg body weight, but these dosages cannot be directly extrapolated to humans. The overall evidence strength is low, and yak spleen extract should be considered investigational pending robust clinical trial data.
Nutritional Profile
Yak spleen extract (Bos grunniens) is a protein-rich organ-derived concentrate with the following compositional characteristics: Protein content is the dominant macronutrient, estimated at 60–75% dry weight, comprising a complex mixture of structural proteins, enzymes, and bioactive peptides including tuftsin (Thr-Lys-Pro-Arg tetrapeptide), splenopentin (pentapeptide fragment), and splenin glycoproteins. Fat content is relatively low at approximately 3–8% dry weight, with phospholipids (primarily phosphatidylcholine and phosphatidylethanolamine) constituting a significant fraction. Carbohydrate content is minimal at 1–5%, largely as glycoprotein-associated oligosaccharides. Key bioactive compounds include: iron-containing proteins (ferritin and hemosiderin, given the spleen's role as an iron-storage organ), with iron concentrations estimated at 150–400 mg/100g dry weight — among the highest of any organ tissue; zinc at approximately 4–8 mg/100g supporting immune enzyme function; copper at 0.5–1.2 mg/100g as a cofactor in ceruloplasmin-related proteins. Nucleoproteins and nucleic acid derivatives (RNA/DNA fragments) are present and may contribute to immunostimulatory effects. Coenzyme Q10 is present at trace levels (~2–5 mg/100g). Vitamin B12 is notably present at an estimated 15–30 µg/100g dry weight. Heme-iron compounds are present and carry high bioavailability (15–35% absorption rate). Spleen-specific immunomodulatory proteins such as splenopentin analogs have demonstrated measurable biological activity at microgram concentrations in preclinical studies. Bioavailability of intact bioactive peptides via oral supplementation is limited due to gastrointestinal proteolysis; hydrolyzed or enteric-coated formulations may improve peptide bioavailability. Data specific to Bos grunniens (yak) versus Bos taurus (domestic cattle) spleen is limited, though yak organ tissues generally show elevated antioxidant enzyme concentrations (superoxide dismutase, catalase) attributed to high-altitude adaptation physiology.
Preparation & Dosage
No human dosage recommendations have been established. Animal studies used low, medium, and high doses of yak-activated protein, with optimal effects observed at medium doses in mice. Specific dosage ranges for human use have not been determined through clinical trials. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Bovine spleen extract, thymus extract, astragalus, reishi mushroom, vitamin C
Safety & Interactions
No well-controlled human safety studies exist for yak spleen extract, making a comprehensive adverse effect profile impossible to establish at this time. As a glandular product derived from bovine tissue, there is a theoretical risk of prion transmission, though commercial processing methods typically aim to mitigate this concern; individuals with immunocompromising conditions should exercise particular caution. Yak spleen extract may theoretically potentiate immunosuppressive drugs such as corticosteroids or calcineurin inhibitors by independently altering lymphocyte activity, warranting medical supervision if combined. Pregnant or breastfeeding individuals should avoid this supplement due to a complete absence of safety data in these populations.